News and Announcements
4Dx Limited Featured on Channel 7 Nationwide
- Published July 03, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Andreas Fouras, 4Dx Chairman and CEO, spoke to Georgia Main from 7 Network News about 4Dx subsidiary Notting Hill Devices’s export of the Preclinical Scanner, and how it drives demand for 4Dx technology. Georgia also spoke with Associate Professor David Parsons, Chief Medical Scientist at the Women’s and Children’s Hospital, Adelaide, about the opportunity that this ground-breaking scanner, which directly integrates with 4Dx software, provides Australian researchers.
Company Updates
The Biofilm Breakthrough: How An Australian BioTech Firm Is Tapping Indonesia’s $45,000-a-Kitchen Bottleneck
Australian sustainability and deep-tech firm Altair International Pty Ltd is commercialising plant-based clinical hygiene technology, targeting a prime operational bottleneck in Indonesia’s massive national free meals program. Every few years, an Australian deep-tech company emerges combining proprietary science with a transformational anchor contract, the kind of business that quietly creates an entirely new market category […]
THE TAX CHANGED. NOW THE PRODUCT IS CHANGING TO MATCH.
Changes to the 50% capital gains tax discount are shifting Australian private capital away from growth and into high-yielding wrappers. Fund managers are actively redesigning products across private credit and property to capture the incoming capital rotation
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula
Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.
Backed By Leading Investment Groups and Family Offices
